ArticleEmerging microbes & infections2021

A bivalent live-attenuated vaccine candidate elicits protective immunity against human adenovirus types 4 and 7.

Jingao Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.